KEGG: spf:SpyM51355
Elongation factor Tu (tuf) is a highly conserved protein involved in protein synthesis in S. pyogenes, playing a critical role in delivering aminoacyl-tRNAs to the ribosome during translation. Its significance in research stems from its stable expression levels across various growth conditions, making it an ideal housekeeping gene for normalizing expression data in RT-qPCR experiments, as demonstrated in studies of the sag operon in S. pyogenes M5 .
When investigating gene expression changes in different genetic backgrounds or experimental conditions, tuf serves as a reliable internal control to obtain accurate relative expression values. Gene expression analyses typically involve extracting RNA from bacteria grown to specific phases, performing DNase treatment using kits like TURBO DNA-free Kit, and synthesizing cDNA with systems such as Protoscript II First Strand cDNA Synthesis . The tuf gene has become a standard reference for normalizing quantitative expression data when studying virulence factors and regulatory pathways in S. pyogenes.
The M5 serotype of S. pyogenes possesses distinct virulence characteristics primarily associated with its M protein structure. As detailed in functional dissection studies, the M5 protein contains specific regions including a hypervariable region (HVR), fibrinogen-binding B-repeats, and C-repeats, each contributing differently to virulence . The M5 protein's B-repeat region binds fibrinogen with high affinity, which significantly contributes to its ability to resist phagocytosis.
Mixed infection experiments have demonstrated that mutants lacking either the HVR or B-repeat regions are strongly attenuated in virulence, while mutants lacking the C-repeats show only slight attenuation . This emphasizes that M5's virulence mechanism relies heavily on both its HVR and fibrinogen-binding regions. Interestingly, studies have shown that the HVR of M5 protein plays a major role in virulence despite not being required for phagocytosis resistance, suggesting additional functions for this region beyond current understanding .
The most efficient approaches for generating recombinant constructs of S. pyogenes tuf gene leverage modern molecular cloning techniques that enable rapid and precise genetic manipulation. Based on methodologies described for other GAS genes, an efficient strategy would involve:
PCR amplification of the tuf gene from S. pyogenes M5 genomic DNA using high-fidelity polymerase and primers designed with appropriate restriction enzyme sites or assembly overhangs.
Implementation of Golden Gate assembly, which has proven effective for GAS gene constructs, allowing one-step assembly of multiple DNA fragments with type IIS restriction enzymes like BsaI .
Cloning into an expression vector containing a strong promoter and suitable tags for purification.
Transformation into E. coli for construct verification and protein expression optimization.
This approach enables the generation of recombinant tuf constructs in approximately 3 days, significantly faster than traditional approaches requiring thermosensitive plasmids that can take up to 2 weeks . For expression of functional recombinant Elongation factor Tu, careful consideration should be given to maintaining proper protein folding and potential post-translational modifications necessary for activity.
Generating non-polar mutations in S. pyogenes genes requires specialized approaches to prevent effects on downstream gene expression. Based on recently developed methodologies, an efficient system includes:
Design of suicide plasmids containing upstream and downstream flanking regions (approximately 1 kb each) of the target gene, with a selectable marker like aphA3 (kanamycin resistance) replacing the gene of interest .
Assembly of these fragments using Golden Gate cloning, which allows precise one-step assembly using type IIS restriction enzymes like BsaI .
Transformation of the construct into S. pyogenes and selection of transformants using appropriate antibiotics (kanamycin for gene replacement).
Discrimination between single (KanᴿSpecᴿ) and double (KanᴿSpecˢ) recombinants by testing for spectinomycin sensitivity, as the vector backbone contains the aad9 (spectinomycin resistance) gene .
Validation of non-polar effects by RT-qPCR analysis of downstream gene expression, as demonstrated in the validation of sagB knockout where researchers confirmed no change in sagC expression levels compared to wild-type .
This method allows generation of non-polar mutants in just 3 days, compared to previous approaches requiring up to 2 weeks, and has been successfully applied to various genes and GAS M-types with success rates between 11% and 93% as shown in the following table:
| Strains | Target gene | Number of reisolated transformants | Number of single recombinants | Number of double recombinants | % of success |
|---|---|---|---|---|---|
| M5 (LO1) | sptR | 56 | 15 | 41 | 73 |
| M75 (Emmy) | mrp | 56 | 33 | 23 | 41 |
| M75 (clinical strain) | emm | 49 | 29 | 20 | 41 |
| M25 (NCTC8306) | emm | 64 | 57 | 7 | 11 |
| M5 (LO1) | isp2 | 45 | 6 | 39 | 87 |
| M1 (SF370) | hasA | 30 | 2 | 28 | 93 |
Optimizing RT-qPCR with tuf as a reference gene for S. pyogenes expression studies requires careful attention to several methodological considerations:
RNA Extraction Protocol: For S. pyogenes, rapid preservation of RNA integrity is crucial. Recommended methodology involves immediately resuspending bacterial cells in RNA protect buffer followed by FastPrep 5G beads disruption for effective lysis of the thick peptidoglycan layer of this Gram-positive bacterium .
DNase Treatment: Thorough removal of genomic DNA contamination is essential, as described in protocols using TURBO DNA-free Kit, to prevent amplification of genomic tuf sequences .
Primer Design for tuf:
Design primers that span exon-exon junctions if possible
Ensure primers have similar annealing temperatures to target gene primers
Validate primer specificity through melt curve analysis
Optimize primer concentrations (typically 100-500 nM)
Validation of tuf Expression Stability:
Verify that tuf expression remains constant under your specific experimental conditions
Consider using multiple reference genes alongside tuf for more robust normalization
Data Analysis:
Apply appropriate normalization formulas (e.g., 2^-ΔΔCt method)
Include technical replicates (at least triplicates) and biological replicates
Apply statistical analysis to determine significance of expression changes
Following these optimization steps will ensure reliable results when using tuf as a reference gene for expression studies, as demonstrated in the analysis of sag operon expression where tuf normalization enabled accurate quantification of gene expression changes in mutant versus wild-type strains .
The most effective approaches for studying M protein contributions to S. pyogenes virulence combine genetic manipulation, biochemical characterization, and in vivo infection models:
Generation of Domain-Specific Deletion Mutants:
Functional Binding Assays:
Mixed Infection Experiments:
Phagocytosis Resistance Testing:
Cross-Functional Analysis:
This comprehensive approach revealed unexpected findings about M5 protein, including the critical role of the HVR in virulence despite not affecting phagocytosis resistance, and the possibility that B-repeats have functions beyond fibrinogen binding .
Elongation factor Tu (tuf) from S. pyogenes M5 exhibits multifunctional properties beyond its canonical role in protein synthesis, particularly in host-pathogen interactions. Although traditionally considered a cytoplasmic protein, research has shown that EF-Tu can be surface-exposed or released during infection, where it interacts with various host immune components:
Complement System Interactions:
EF-Tu may bind complement regulators similar to other bacterial moonlighting proteins
This interaction potentially contributes to complement evasion mechanisms
Fibrinogen Binding Potential:
Pattern Recognition Receptor Activation:
As a highly conserved bacterial protein, EF-Tu contains pathogen-associated molecular patterns (PAMPs)
These PAMPs can be recognized by host pattern recognition receptors, triggering inflammatory responses
Understanding these interactions requires sophisticated experimental approaches including protein-protein interaction studies, immune cell stimulation assays, and in vivo models examining the contribution of EF-Tu to virulence alongside established virulence factors like the M5 protein .
The interaction between recombinant S. pyogenes proteins and host fibrinogen reveals distinct mechanistic aspects of pathogenesis:
Binding Specificities:
M5 protein binds fibrinogen primarily through its B-repeat region, which is essential for virulence
The binding efficiency of M5 to mouse and human fibrinogen is comparable, making mouse models appropriate for studying this interaction
Binding studies using radiolabeled proteins demonstrated that M5 can bind immobilized fibrinogen of various species with similar efficacy
Experimental Evidence:
Dot-blot assays with immobilized fibrinogens and radiolabeled M5 protein show equivalent binding to mouse and human fibrinogen
Binding assays with whole bacteria demonstrated that wild-type S. pyogenes M5 strains bound both mouse and human fibrinogen, while ΔB mutants lacking B-repeats did not bind either
When incubated with whole plasma, M5-expressing bacteria selectively captured fibrinogen from both mouse and human plasma samples, confirming specificity
Virulence Correlation:
Mixed infection experiments showed that M5 mutants lacking the B-repeat region (ΔB) were strongly attenuated, similar to complete M5 deletion mutants
Unexpectedly, B-repeat mutants remained attenuated even in fibrinogen-deficient mice, suggesting the B-repeats have additional functions beyond fibrinogen binding
Methodological Approaches:
Competitive binding assays with recombinant proteins can determine if Elongation factor Tu competes with M5 for fibrinogen binding
Surface plasmon resonance analysis can provide precise binding kinetics and affinities
Structural studies may reveal the molecular basis for these interactions
Understanding the distinct and potentially complementary interactions of these proteins with host fibrinogen provides crucial insights into S. pyogenes pathogenesis mechanisms and may guide the development of novel therapeutic approaches.
Advanced genetic manipulation approaches for studying tuf gene function across different S. pyogenes M-types include:
One-Step Non-Polar Mutation System:
Recently developed methods allow generation of non-polar mutations in GAS in just 3 days compared to traditional 2-week approaches
The system uses suicide plasmids with flanking regions of the target gene and the aphA3 gene (kanamycin resistance) as a selective marker
Golden Gate assembly enables precise one-step construction of these plasmids
This approach has been successfully applied across various GAS backgrounds (M-types) with success rates between 11-93%
Counter-Selection Strategies:
Implementation of mutated pheS gene as a counter-selective marker for double recombination events
This allows efficient isolation of double recombinants through negative selection on chlorophenylalanine-containing media
For essential genes like tuf, conditional approaches using this system could be developed
Cross-M-type Applicability:
Validation Methods:
These advanced approaches enable more efficient functional characterization of tuf across diverse S. pyogenes strains, potentially revealing strain-specific variations in elongation factor function and contribution to virulence.
Future research on recombinant S. pyogenes M5 Elongation factor Tu should focus on several promising directions:
Comprehensive Functional Mapping:
Structural and functional characterization of specific EF-Tu domains
Investigation of potential moonlighting functions beyond translation
Comparative analysis of EF-Tu across different S. pyogenes M-types
Host-Pathogen Interaction Studies:
Detailed examination of potential interactions between EF-Tu and host immune components
Investigation of possible synergies between EF-Tu and M protein in virulence
Exploration of how EF-Tu contributes to immune evasion strategies
Methodological Innovations:
Therapeutic Applications:
Evaluation of EF-Tu as a potential broad-spectrum vaccine component
Assessment of EF-Tu as a target for novel antimicrobial compounds
Investigation of how EF-Tu modifications affect antibiotic susceptibility